ClinicalTrials.Veeva

Menu

Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

A

Assiut University

Status

Not yet enrolling

Conditions

PSA Changes After TURP

Treatments

Procedure: TURP

Study type

Interventional

Funder types

Other

Identifiers

NCT05533047
PSA Changes after TURP

Details and patient eligibility

About

To use PSA levels after bipolar and monopolar transurethral resection of the benign prostatic hyperplasia as an indicator of the quality of resection .

Full description

PSA is a protein produced from the prostate epithelium and secreted in semen in huge amounts , small amount find its way to the circulation ,its function is to allow mobility of the sperms by interacting with the Semenogelin . clinical BPH can be defined as prostate adenoma/adenomata, causing a varying degree of BOO, which may eventually cause harm to the patients ,Treatment of this condition varies from conservative, medical and surgical depending on factors related to the patient and the surgeon preference . The early reports of minimally invasive treatment of the prostate dated back to 1937, since then and remarkable development is noticed . TURP is the golden treatment in the BPH . Studies compare between the methods according the blood transfusion , operation time retention after catheter removal , urethral complications , TUR syndrome and hospital-stay which show that bipolar is better. To our knowledge after few studies compare between the techniques according PSA also these studies show weakness in their statistically analysis with no difference between the methods .investigators aim is to study the effect of the operations on PSA levels as an indicator of the quality of resection.

Enrollment

2 estimated patients

Sex

Male

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients agreeing to participate, clinically fit, age from 50 to 80 years with LUTS related to benign prostate enlargement with no neurological disorder

Exclusion criteria

  • Prostate cancer
  • Previous urethral or prostate surgery
  • Neurogenic bladder
  • Urethral stricture
  • Patient unfit for surgery

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2 participants in 2 patient groups

Bipolar TURP
Active Comparator group
Description:
Patients thats will undergo bipolar TURP
Treatment:
Procedure: TURP
Monopolar TURP
Active Comparator group
Description:
Patients thats will undergo monopolar TURP
Treatment:
Procedure: TURP

Trial contacts and locations

0

Loading...

Central trial contact

Mahmoud M Shalaby, professor; Andrew H Wahba Gerges, Resident doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems